Policy, Access, Value, and Evidence

Accelerating access to novel therapies through global strategic consultancy and pioneering digital solutions

From the US to Asia-Pacific and across Europe, clients depend on our unique Policy, Access, Value, and Evidence capabilities to optimize access and demonstrate the full value of their innovative products to payers.

From early-stage development through to successful launch and beyond, we help access, HEOR, and cross-functional teams strengthen their understanding of complex market access risks and opportunities. We accelerate the development of robust evidence and deliver strategies that identify and communicate value to meet payers' evolving requirements.

Our multidisciplinary, technology-enabled consultancy is shaping the market; we look forward to partnering with you to solve your complex Policy, Access, Value, and Evidence challenges.

Our Policy, Access, Value, and Evidence services include:

• Market access landscape and opportunity assessments
• Pricing, reimbursement, and market access strategy
• Payer value strategy and communications
• Payer and key opinion leader engagement
• Economic modeling and synthesis
• Real-world evidence planning and analytics
• Patient support programs and services
• Pricing and contracting strategy
• Life-cycle management strategy
• Digital applications for market access
• Evidence generation
• Health economics and outcomes research
• Federal and State policy
• Due diligence